Medacta Group (MEDGF) Short Interest Ratio & Short Volume $83.91 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Medacta Group Short Interest DataMedacta Group (MEDGF) has a short interest of 29,900 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 200 shares to cover all short positions.Current Short Interest29,900 sharesPrevious Short Interest29,900 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$2.51 millionShort Interest Ratio0.0 Days to CoverLast Record DateMarch 15, 2025Today's Trading Volume0 sharesAverage Trading Volume200 sharesToday's Volume Vs. Average0% Short Selling Medacta Group? Sign up to receive the latest short interest report for Medacta Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDGF Short Interest Over TimeMEDGF Days to Cover Over TimeMEDGF Percentage of Float Shorted Over Time Remove Ads Medacta Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202529,900 shares $2.51 million No ChangeN/A0 $83.91 2/28/202529,900 shares $2.51 million No ChangeN/A0 $83.91 2/15/202529,900 shares $2.51 million +56.5%N/A0 $83.91 1/31/202519,100 shares $1.60 million No ChangeN/A0 $83.91 1/15/202519,100 shares $1.60 million No ChangeN/A95.5 $83.91 12/31/202419,100 shares $1.60 million No ChangeN/A191 $83.91 12/15/202419,100 shares $1.60 million -9.5%N/A0 $83.91 11/30/202421,100 shares $1.77 million -1.9%N/A0 $83.91 11/15/202421,500 shares $1.80 million -0.9%N/A0 $83.91 10/31/202421,700 shares $1.82 million +61.9%N/A0 $83.91 Get the Latest News and Ratings for MEDGF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medacta Group and its competitors with MarketBeat's FREE daily newsletter. 10/15/202413,400 shares $1.12 million -10.7%N/A0 $83.91 9/30/202415,000 shares $1.26 million -1.3%N/A0 $83.91 9/15/202415,200 shares $1.28 million -0.7%N/A0 $83.91 8/31/202415,300 shares $1.28 million -6.7%N/A0 $83.91 8/15/202416,400 shares $1.38 million +1.2%N/A0 $83.91 7/31/202416,200 shares $1.36 million -2.4%N/A0 $83.91 7/15/202416,600 shares $1.39 million -9.8%N/A0 $83.91 6/30/202418,400 shares $1.54 million +4.6%N/A0 $83.91 6/15/202417,600 shares $1.48 million -2.8%N/A0 $83.91 5/31/202418,100 shares $1.52 million +11.0%N/A0 $83.91 5/15/202416,300 shares $1.37 million -23.5%N/A163 $83.91 4/30/202421,300 shares $1.79 million +88.5%N/A0 $83.91 4/15/202411,300 shares $948,183.00 +29.9%N/A0 $83.91 3/31/20248,700 shares $730,017.00 +4.8%N/A0 $83.91 3/15/20248,300 shares $696,453.00 No ChangeN/A0 $83.91 2/29/20248,300 shares $696,453.00 -56.8%N/A0 $83.91 2/15/202419,200 shares $1.61 million No ChangeN/A0 $83.91 1/15/202420,500 shares $1.72 million +2.5%N/A0 $83.91 12/31/202320,000 shares $1.68 million -5.7%N/A0 $83.91 12/15/202321,200 shares $1.78 million +72.4%N/A0 $83.91 11/30/202312,300 shares $1.03 million -3.9%N/A0 $83.91 11/15/202312,800 shares $1.07 million +6.7%N/A0 $83.91 10/31/202312,000 shares $1.01 million -35.8%N/A0 $83.91 10/15/202318,700 shares $1.57 million +33.6%N/A0 $83.91 9/30/202314,000 shares $1.17 million +21.7%N/A0 $83.91 9/15/202311,500 shares $964,965.00 -5.0%N/A0 $83.91 8/31/202312,100 shares $1.02 million +2.5%N/A0 $83.91 8/15/202311,800 shares $990,138.00 -5.6%N/A0 $83.91 7/31/202312,500 shares $1.05 million +9.7%N/A0 $83.91 7/15/202311,400 shares $956,574.00 -10.2%N/A0 $83.91Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 6/30/202312,700 shares $1.07 million -18.6%N/A0 $83.91 6/15/202315,600 shares $1.31 million +4.0%N/A0 $83.91 5/31/202315,000 shares $1.26 million -5.1%N/A0 $83.91 5/15/202315,800 shares $1.33 million +30.6%N/A0 $83.91 4/30/202312,100 shares $1.02 million -4.7%N/A0 $83.91 4/15/202312,700 shares $1.07 million -16.5%N/A0 $83.91 3/31/202315,200 shares $1.28 million +18.8%N/A0 $83.91 3/15/202312,800 shares $1.07 million -0.8%N/A128 $83.91 2/28/202312,900 shares $1.08 million -5.8%N/A0 $83.91 2/15/202313,700 shares $1.15 million -2.1%N/A0 $83.91 1/31/202314,000 shares $1.17 million -2.8%N/A0 $83.91 1/15/202314,400 shares $1.21 million -3.4%N/A0 $83.91 12/30/202214,900 shares $1.25 million -1.3%N/A0 $83.91 12/15/202215,100 shares $1.27 million -9.0%N/A151 $83.91 11/30/202216,600 shares $1.39 million +1.8%N/A0 $83.91 11/15/202216,300 shares $1.37 million +3.8%N/A163 $83.91 10/31/202215,700 shares $1.32 million -11.3%N/A0 $83.91 10/15/202217,700 shares $1.49 million +12.0%N/A0 $83.91 9/30/202215,800 shares $1.33 million +690.0%N/A158 $83.91 9/15/20222,000 shares $172,655.00 -44.4%N/A20 $86.33 8/31/20223,600 shares $309,600.00 -5.3%N/A0 $86.00 8/15/20223,800 shares $326,800.00 +81.0%N/A0 $86.00 7/31/20222,100 shares $180,600.00 -44.7%N/A21 $86.00 7/15/20223,800 shares $326,800.00 +31.0%N/A38 $86.00 6/30/20222,900 shares $359,600.00 No ChangeN/A0 $124.00 6/15/20222,900 shares $359,600.00 -56.1%N/A0 $124.00 5/31/20226,600 shares $818,400.00 +73.7%N/A0 $124.00 5/15/20223,800 shares $471,200.00 -44.1%N/A0 $124.00 4/30/20226,800 shares $843,200.00 +1.5%N/A0 $124.00 4/15/20226,700 shares $830,800.00 +48.9%N/A0 $124.00 3/31/20224,500 shares $558,000.00 -73.5%N/A0 $124.00 3/15/202217,000 shares $2.11 million +6.9%N/A170 $124.00 2/28/202215,900 shares $2.27 million +9.7%N/A0 $143.00 2/15/202214,500 shares $2.07 million +400.0%N/A0 $143.00 1/31/20222,900 shares $414,700.00 +480.0%N/A29 $143.00 1/15/2022500 shares $0.00 No ChangeN/A5 $0.00 12/31/2021500 shares $71,500.00 -16.7%N/A5 $143.00 12/15/2021600 shares $85,800.00 +500.0%N/A0 $143.00 11/30/2021100 shares $14,300.00 -93.3%N/A1 $143.00 11/15/20211,500 shares $185,250.00 +36.4%N/A0 $123.50 10/29/20211,100 shares $135,850.00 -45.0%N/A11 $123.50 10/15/20212,000 shares $247,000.00 +100.0%N/A0 $123.50 9/30/20211,000 shares $123,500.00 +25.0%N/A0 $123.50 9/15/2021800 shares $98,800.00 -20.0%N/A0 $123.50 8/31/20211,000 shares $123,500.00 +100.0%N/A0 $123.50 8/13/2021500 shares $61,750.00 -16.7%N/A0 $123.50 7/30/2021600 shares $74,100.00 +50.0%N/A0 $123.50 7/15/2021400 shares $49,400.00 No ChangeN/A0 $123.50 6/30/2021400 shares $49,400.00 -81.0%N/A4 $123.50 6/15/20212,100 shares $259,350.00 +23.5%N/A21 $123.50Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 5/28/20211,700 shares $0.00 +240.0%N/A17 $0.00 MEDGF Short Interest - Frequently Asked Questions What is Medacta Group's current short interest? Short interest is the volume of Medacta Group shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 29,900 shares of MEDGF short. Learn More on Medacta Group's current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Medacta Group stock? Short selling MEDGF is an investing strategy that aims to generate trading profit from Medacta Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medacta Group? A short squeeze for Medacta Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDGF, which in turn drives the price of the stock up even further. How often is Medacta Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDGF, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies BICO Group AB (publ) Short Squeeze Caliber Imaging & Diagnostics Short Squeeze CellaVision AB (publ) Short Squeeze Cochlear Short Squeeze Demant A/S Short Squeeze Drägerwerk AG & Co. KGaA Short Squeeze Electromedical Technologies Short Squeeze Embla Medical hf. Short Squeeze Evome Medical Technologies Short Squeeze GN Store Nord A/S Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDGF) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medacta Group SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Medacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDGF Stock Free MEDGF Stock Alerts